Key result
Current guidelines for detecting anthracycline-induced cardiotoxicity lack uniformity, highlighting the need for novel circulating biomarkers like microRNAs to enable early risk assessment.
Answers are grounded in this paper and cite their sources.
This editorial highlights the need for a uniform definition of anthracycline-induced cardiotoxicity and emphasizes the potential of novel circulating biomarkers, such as microRNAs, for early risk assessment.
Cardio toxicity in oncologic patients
No takes yet. Share an insight, caveat, or question.
A 2018 study conducted an editorial in Anthracycline-induced cardiotoxicity. Anthracyclines was evaluated. Current guidelines for detecting anthracycline-induced cardiotoxicity lack uniformity, highlighting the need for novel circulating biomarkers like microRNAs to enable early risk assessment.
Synapse has enriched 10 related papers. Consider them for comparative context: